Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 421-450-8 | CAS number: 154702-15-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: oral
Administrative data
- Endpoint:
- sub-chronic toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1997
- Reliability:
- 1 (reliable without restriction)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 997
- Report date:
- 1997
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 408 (Repeated Dose 90-Day Oral Toxicity Study in Rodents)
- GLP compliance:
- yes (incl. QA statement)
- Limit test:
- yes
Test material
- Reference substance name:
- -
- EC Number:
- 421-450-8
- EC Name:
- -
- Cas Number:
- 154702-15-5
- Molecular formula:
- C44H59N7O5
- IUPAC Name:
- 2-ethylhexyl 4-[(4-{[4-(tert-butylcarbamoyl)phenyl]amino}-6-[(4-{[(2-ethylhexyl)oxy]carbonyl}phenyl)amino]-1,3,5-triazin-2-yl)amino]benzoate
- Details on test material:
- Name of the test substance: RA 3643
Appearance: white powder
Batch no. : 51/95
Date of receipt: 1995-12-21
Storage: at room temperature, dark
Used for: validation of the analytical method for the determination of RA 3643 in the diet
Batch no. : 74
Date of receipt: 1996-02-01
Storage: at room temperature, dark
Used for: 14 day range-finding study and determination of the stability of RA 3643 in the diet
Batch no. : 87/96
Date of receipt: 1996-04-15
Storage: initially at room temperature in the dark, from 1996-04-23 in a refirgerator (2-10°C)
Used for: sub chronic toxicity study
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Male (46) and female (46) Wistar rats were obtained from a colony maintained under SPF-conditions at Charles River Wiga GmbH, Sulzfeld Germany. They were about 4 weeks old.
The body weights on the experimental start date ranged from 157.4 g to 189.1 g for males, and from 118.2 g to 145.2 g for females.
Housing conditions were conventional. The number of air changes was about 10 per hour, and lighting was artificial by fluorescent tubes, time switch controlled at a sequence of 12 h light (7.30-19.30), 12 h dark. The temperature and relative humidity in the experimental room, monitored continuously by means of a thermohygrograph, were 22-24°C and 50-70%, respectively.
Occasionally, the values were out of these ranges. The temperature exceeded the upper value twice.
The humidity was lower than 50% for two periods of a few hours and higher than 70% for three such short periods. In addition, the humidity exceeded 70% for about ten longer periods.
From the start of the treatment period, the animals were housed in groups of five, separated by sex, in suspended stainless steel cages with wire mesh floor and front. During the acclimatization period they were housed in similar cages in groups of five or six.
Feed (in powder) and water (tap water) were provided ad libitum from the arrival of the rats until the end of the study.
Administration / exposure
- Route of administration:
- oral: feed
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- The oral route was used because this route is recommended in the guidelines for testing of cosmetic ingredients for their safety evaluation. The TNO rodent diet was used as the carrier. The test substance was incorporated into this diet by mixing in a mechanical blender. Because the test substance contained particles of different sizes, the substance was ground in an electric coffee mill prior to diet mixing. Fresh batches of experimental diets were prepared at 2-3 week intervals and stored at c.-20°C in a freezer until use.
- Analytical verification of doses or concentrations:
- yes
- Duration of treatment / exposure:
- The test substance was administered in the diet, at constant concentrations, for 13 consecutive weeks.
- Frequency of treatment:
- in the diet
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
0.15 % w/w
Basis:
nominal in diet
- Remarks:
- Doses / Concentrations:
0.5 % w/w
Basis:
nominal in diet
- Remarks:
- Doses / Concentrations:
1.5 % w/w
Basis:
nominal in water
- No. of animals per sex per dose:
- Four groups of 10 males and 10 females each: a vehicle control group and three test groups.
- Control animals:
- yes, concurrent vehicle
Examinations
- Observations and examinations performed and frequency:
- Each animal was observed:
- clinical signs
- body weight
- food consumption and food efficiency
- intake of the test substance
- water consumption
- ophthalmoscopic examination
- haematology
- clinical chemistry
- renal concentration test and urinalysis
- gross necropsy
- histopathological examination
Results and discussion
Results of examinations
- Clinical signs:
- no effects observed
- Mortality:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
- Food efficiency:
- no effects observed
- Water consumption and compound intake (if drinking water study):
- no effects observed
- Ophthalmological findings:
- no effects observed
- Haematological findings:
- no effects observed
- Clinical biochemistry findings:
- no effects observed
- Urinalysis findings:
- no effects observed
- Behaviour (functional findings):
- no effects observed
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Gross pathological findings:
- no effects observed
- Histopathological findings: non-neoplastic:
- no effects observed
- Histopathological findings: neoplastic:
- no effects observed
- Details on results:
- The concentrations of the test substance found in diet samples analyzed after storage in the animal room for 7 days or in a freezer for five weeks showed that the substance was stable under simulated experimental conditions. Analysis of 5 samples per diet, taken at different locations, showed that the test substance was homogeneously distributed in the diet at all dose levels.The content of the test substance was close to the intended level in all diets analyzed.
Effect levels
open allclose all
- Dose descriptor:
- NOAEL
- Effect level:
- 831 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Sex:
- male
- Basis for effect level:
- body weight and weight gain
- clinical biochemistry
- clinical signs
- food consumption and compound intake
- food efficiency
- gross pathology
- haematology
- histopathology: neoplastic
- histopathology: non-neoplastic
- mortality
- ophthalmological examination
- urinalysis
- water consumption and compound intake
- Dose descriptor:
- NOAEL
- Effect level:
- 963 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Sex:
- female
- Basis for effect level:
- body weight and weight gain
- clinical biochemistry
- clinical signs
- food consumption and compound intake
- food efficiency
- gross pathology
- haematology
- histopathology: neoplastic
- histopathology: non-neoplastic
- mortality
- ophthalmological examination
- urinalysis
- water consumption and compound intake
Target system / organ toxicity
- Critical effects observed:
- not specified
Any other information on results incl. tables
The objective of this study was to examine the possible sub chronic oral toxicity of the test substance RA 3643 in rats. This substance was administered in the diet, at concentrations of 0, 0.15, 0.5 or 1.5%, to groups of 10 males and 10 female Wistar rats for 13 consecutive weeks.
The ingestion of RA 3643 was well tolerated, as evidenced by the absence of treatment-related changes in the appearance, general condition and behaviour of the animals, their growth, food and water consumption, red blood cell and cloting potential values, total white blood cell counts, clinical chemistry values, renal concentrating ability, composition of the urine, organ weights, gross necropsy findings and histopathological findings.
In comparison with the controls, the mean percentage of neutrophils was higher and that of lymphocytes lower in all groups of female rats given RA 3643.
The differences showed no dose-response relationship and probably resulted from the relatively low neutrophil and high lymphocyte count in the control group.
Most importantly, the differences were not reflected in dose-related or significant changes in the absolute numbers of these cell types and are, therefore, regarded as chance findings, unrelated to treatment.
Applicant's summary and conclusion
- Conclusions:
- Since the ingestion of RA 3643 at dietary levels up to 1.5% for 13 consecutive weeks was tolerated without signs of toxicity, the dietary concentration of 1.5% was a no-observed-adverse-effect level of RA 3643 under the conditions of this study. This dietary level provided a mean intake of 831 and 963 mg of RA 3643/kg body weight/day in male and female rats, respectively.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.